4:10 pm to 5:00 pm
Improving Lung Cancer Radiotherapy with Advanced Imaging Technologies
Lung cancer is the leading cause of cancer death in the US and worldwide. In 2014, approximately 224,210 new cases of lung or bronchial cancer were expected to be diagnosed in the US, and 159,260 patients (71%) were estimated to die of this disease. Approximately 60% of lung cancer patients will require radiotherapy at least once in North America. Overall survival for lung cancer remains disappointing and toxicity is substantial, particularly for advanced disease. Our goal is to improve therapeutic gains in lung cancer radiotherapy through personalizing treatment with advanced imaging technologies. This presentation will describe our ongoing and planned projects focused on developing and investigating anatomic, functional and metabolic imaging technologies, and integrating these innovations into clinical radiotherapy for lung cancer.